Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDana-Farber Cancer Institute
About this trial
This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resources about leukemia and clinical trial participation.
Eligibility criteria
Qualifiers
Age 18 or older
English speaking
Ability to understand and willingness to sign written informed consent
Clinical suspicion of acute leukemia
Disqualifiers
Cognitive impairment rendering the individual unable to participate in beta testing
This will be assessed by focused chart review and consultation with the patients' inpatient care team.
The following populations will be excluded: adults unable to consent, individuals who are not yet adults (infants, children, teenagers <18 years old), prisoners.
Inability to participate in in-person application testing.
Trial design
Treatments tested in this trial
- TRIAL Web-Based Application
Treatment groups
75 Participants
are divided into 1 treatment groupSponsors and collaborators
Dana-Farber Cancer Institute
Lead sponsor
American Society of Clinical Oncology
Collaborator
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov